☰

Brian M. Nolen, Ph.D. - Publications

Affiliations: 
2011 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Public Health, Oncology
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Nolen BM, Lomakin A, Marrangoni A, Velikokhatnaya L, Prosser D, Lokshin AE. Urinary protein biomarkers in the early detection of lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 8: 111-9. PMID 25416410 DOI: 10.1158/1940-6207.Capr-14-0210  0.675
2014 Nolen BM, Breen EC, Bream JH, Jenkins FJ, Kingsley LA, Rinaldo CR, Lokshin AE. Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma. Plos One. 9: e99144. PMID 24922518 DOI: 10.1371/Journal.Pone.0099144  0.526
2014 Nolen BM, Brand RE, Prosser D, Velikokhatnaya L, Allen PJ, Zeh HJ, Grizzle WE, Huang Y, Lomakin A, Lokshin AE. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. Plos One. 9: e94928. PMID 24747429 DOI: 10.1371/Journal.Pone.0094928  0.679
2014 Nolen BM, Grizzle W, Brand R, Lokshin AE. Abstract 295: Urine and serum biomarkers of pancreatic cancer Cancer Research. 74: 295-295. DOI: 10.1158/1538-7445.Am2014-295  0.678
2013 Nolen BM, Orlichenko LS, Marrangoni A, Velikokhatnaya L, Prosser D, Grizzle WE, Ho K, Jenkins FJ, Bovbjerg DH, Lokshin AE. An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. Plos One. 8: e63368. PMID 23723977 DOI: 10.1371/Journal.Pone.0063368  0.613
2013 Nolen BM, Lokshin AE. Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Molecular Diagnosis & Therapy. 17: 139-46. PMID 23552992 DOI: 10.1007/S40291-013-0027-6  0.687
2013 Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, et al. Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 24: 741-8. PMID 23378139 DOI: 10.1007/S10552-013-0156-6  0.636
2012 Nolen BM, Lokshin AE. Multianalyte assay systems in the differential diagnosis of ovarian cancer. Expert Opinion On Medical Diagnostics. 6: 131-138. PMID 22468148 DOI: 10.1517/17530059.2012.661711  0.622
2012 Nolen B. The expansion and advancement of cancer biomarkers. Cancer Biomarkers : Section a of Disease Markers. 10: 61-2. PMID 22430132 DOI: 10.3233/CBM-2012-0244  0.445
2012 Nolen BM, Lokshin AE. Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncology (London, England). 8: 55-71. PMID 22149035 DOI: 10.2217/Fon.11.135  0.722
2012 Nolen BM, Lomakin A, Bast R, Lu K, Marrangoni A, Lokshin AE. Abstract 3573: Urine and serum biomarkers as early detection tools for ovarian cancer Cancer Research. 72: 3573-3573. DOI: 10.1158/1538-7445.Am2012-3573  0.731
2011 Nolen BM, Langmead CJ, Choi S, Lomakin A, Marrangoni A, Bigbee WL, Weissfeld JL, Wilson DO, Dacic S, Siegfried JM, Lokshin AE. Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomarkers : Section a of Disease Markers. 10: 3-12. PMID 22297547 DOI: 10.3233/Cbm-2012-0229  0.63
2011 Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, Gu Y, Hallmans G, Idahl A, Krogh V, Lokshin AE, Lundin E, Muti P, Marrangoni A, Nolen BM, Ohlson N, et al. Factors associated with inflammation markers, a cross-sectional analysis. Cytokine. 56: 769-78. PMID 22015105 DOI: 10.1016/J.Cyto.2011.09.013  0.572
2011 Nolen BM, Lokshin AE. -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. The International Journal of Biological Markers. 26: 141-52. PMID 21928247 DOI: 10.5301/Jbm.2011.8613  0.71
2011 Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, et al. Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 799-810. PMID 21467242 DOI: 10.1158/1055-9965.Epi-10-1180  0.578
2011 Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD, Vickers SM, Langmead CJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE. Serum biomarker panels for the detection of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 805-16. PMID 21325298 DOI: 10.1158/1078-0432.Ccr-10-0248  0.69
2011 Nolen BM, Lomakin A, Grizzle WE, Jhala N, Eloubeidi MA, Christein JD, Arnoletti JP, Oelschlager DK, Vickers SM, Lokshin AE. Abstract 3181: The combined use of urine and serum biomarkers in early detection strategies for pancreatic cancer Cancer Research. 71: 3181-3181. DOI: 10.1158/1538-7445.Am2011-3181  0.691
2010 Nolen BM, Lokshin AE. Screening for ovarian cancer: old tools, new lessons. Cancer Biomarkers : Section a of Disease Markers. 8: 177-86. PMID 22045352 DOI: 10.3233/Cbm-2011-0210  0.697
2010 Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E. Temporal reliability of cytokines and growth factors in EDTA plasma. Bmc Research Notes. 3: 302. PMID 21073739 DOI: 10.1186/1756-0500-3-302  0.577
2010 Nolen BM, Lokshin AE. Autoantibodies for cancer detection: still cause for excitement? Cancer Biomarkers : Section a of Disease Markers. 6: 229-45. PMID 20938084 DOI: 10.3233/Cbm-2009-0137  0.679
2010 Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a multimarker assay for early detection of ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2159-66. PMID 20368574 DOI: 10.1200/Jco.2008.19.2484  0.677
2010 Nolen B, Velikokhatnaya L, Marrangoni A, De Geest K, Lomakin A, Bast RC, Lokshin A. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecologic Oncology. 117: 440-5. PMID 20334903 DOI: 10.1016/J.Ygyno.2010.02.005  0.581
2010 Nolen BM, Lokshin AE. Targeting CCL11 in the treatment of ovarian cancer. Expert Opinion On Therapeutic Targets. 14: 157-67. PMID 20055715 DOI: 10.1517/14728220903512983  0.655
2010 Nolen B, Lomakin A, Bigbee WL, Siegfried J, Lokshin A. Serum biomarkers for early detection of lung cancer. Journal of Clinical Oncology. 28: e21057-e21057. DOI: 10.1200/Jco.2010.28.15_Suppl.E21057  0.668
2010 Nolen BM, Lomakin A, Bast R, Lu K, Grizzle WE, Jhala NC, Eloubeidi MA, Christein JD, Arnoletti JP, Oelschlager DK, Vickers SM, Marrangoni A, Lokshin A. Abstract 4567: Urine biomarkers outperform serum biomarkers in the diagnosis of various human cancers Cancer Research. 70: 4567-4567. DOI: 10.1158/1538-7445.Am10-4567  0.719
2009 Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Biological significance of prolactin in gynecologic cancers. Cancer Research. 69: 5226-33. PMID 19491263 DOI: 10.1158/0008-5472.Can-08-4652  0.645
2009 Levina V, Nolen BM, Marrangoni AM, Cheng P, Marks JR, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Role of eotaxin-1 signaling in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2647-56. PMID 19351767 DOI: 10.1158/1078-0432.Ccr-08-2024  0.657
2009 Nolen B, Winans M, Marrangoni A, Lokshin A. Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. Journal of Immunological Methods. 344: 116-20. PMID 19348809 DOI: 10.1016/J.Jim.2009.03.017  0.619
2008 Nolen B, Marrangoni A, Velikokhatnaya L, Prosser D, Winans M, Gorelik E, Lokshin A. A serum based analysis of ovarian epithelial tumorigenesis. Gynecologic Oncology. 112: 47-54. PMID 19007974 DOI: 10.1016/J.Ygyno.2008.09.043  0.621
2008 Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E. Chemotherapeutic drugs and human tumor cells cytokine network. International Journal of Cancer. 123: 2031-40. PMID 18697197 DOI: 10.1002/Ijc.23732  0.567
2008 Nolen BM, Marks JR, Ta'san S, Rand A, Luong TM, Wang Y, Blackwell K, Lokshin AE. Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Research : Bcr. 10: R45. PMID 18474099 DOI: 10.1186/Bcr2096  0.635
2007 Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 102-7. PMID 17220337 DOI: 10.1158/1055-9965.Epi-06-0602  0.665
2006 Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecologic Oncology. 102: 244-51. PMID 16434085 DOI: 10.1016/J.Ygyno.2005.12.011  0.678
Show low-probability matches.